# Safety Study of GS-5806 to Treat Respiratory Syncytial Virus (RSV)

> **NCT01797419** · PHASE1 · WITHDRAWN · sponsor: **Gilead Sciences**

## Conditions studied

- Respiratory Syncytial Virus Infections

## Interventions

- **DRUG:** GS-5806
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT01797419
- **Lead sponsor:** Gilead Sciences
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2013-05
- **Primary completion:** 2013-08
- **Final completion:** 2013-08
- **Target enrollment:** 0 (ACTUAL)
- **Last updated:** 2013-10-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01797419

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01797419, "Safety Study of GS-5806 to Treat Respiratory Syncytial Virus (RSV)". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT01797419. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*